BCL2L1 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, the BCL2L1 gene shows differential splicing in both AML and CML [99,102], promoting the anti-apoptotic form BCL-XL, thus explaining a survival advantage and TKI resistance [102].